|
|
 |
VIZAMYL Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VYZULTA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
XIGDUO XR Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
TROMETHAMINE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VEKLURY Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VERZENIO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
XENLETA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|